CD44 and breast cancer: In the T47D breast cancer cell line, expression of PRB increased the CD44+/CD24Low/− subpopulation, and even though the number of tumorspheres did not vary between the T47D, YB, and YA cell lines, those generated from YB were bigger, more irregular and had increased clonogenic capacity.